During the COVID-19 pandemic, a debate started on the safety of smoke evacuation in the surgical field, due to the hypothesis that the virus can be produced during an aerosol-generating procedure (AGP). An AGP is defined as a medical or surgical procedure that can induce the production of aerosols of any size, either during open or minimally invasive approaches.[@bib1]

Since the hepatitis B virus (HBV) has previously been demonstrated to be present in surgical smoke in 10 out of 11 HBV positive patients, it is feared that the SARS-CoV-2/COVID-19 virus could also be disseminated during AGPs and potentially infect the surgical staff. However, SARS-CoV-2/COVID-19 virus has not yet been detected in surgical smoke or aerosols produced during open or minimally invasive surgery.[@bib2] ^,^ [@bib3]

Given the potential transmission risk of SARS-CoV-2/COVID-19 through AGPs, care should be taken to reduce the risk of surgical staff infection, and a cost-effective measure for the evacuation and entrapment of surgical smoke and aerosol is needed. We suggest the use of a simple and very low-cost extraction and filtration system with readily available components in the operating room for immediate implementation during open or laparoscopic surgery in low and middle-income countries.

We present a prospective study of two low-cost devices made to mitigate the risk of SARS-CoV-2/COVID-19 infection during surgical procedures, in three healthcare centers in Bogotá, Colombia. The devices were proven in patients who underwent either open or laparoscopic surgery. The need for written informed consent from each patient was waived since we prospectively collected and analyzed all data from each patient. All of the patients were informed about the benefits of these low-cost instruments, both for the patient as for the healthcare provider. The procedures were performed in a negative pressure OR when possible. The OR team consisted of only the critical staff: 2 surgeons, 1 anesthesiologist, 1 nursing assistant, 1 scrub nurse, and 1 circulating nurse with full personal protective equipment (PPE). The surgical smoke and the induced pneumoperitoneum were evacuated using a homemade surgical smoke extractor attached to the open or laparoscopic electrosurgery device and connected to a water seal trap with sodium hypochlorite.

The open surgical smoke extractor was made using a suction tube. The suction tube was divided partially in its distal portion and attached to the electrosurgery open device with two elastic sterile bands, surrounding the tip with a distance less of 5 mm from the surgical field **(** [Fig. 1](#fig1){ref-type="fig"} **).** The total estimated price is 5 American dollars.Fig. 1A. Open surgery low cost device during a procedure.B. Suction tube attached to the electrosurgery open device.Source: Pictures taken by the authors.Fig. 1

The laparoscopic surgical smoke extractor was made using an intravenous extension set. It was cut in its distal portion and attached to the laparoscopic advanced energy device with four elastic sterile bands, near the tip. This allows the simultaneous entrance of the laparoscopic advanced energy device with the laparoscopic surgical smoke extractor through a 10 mm laparoscopic port ([Fig. 2](#fig2){ref-type="fig"} ). The total estimated price is 12 American dollars.Fig. 2Low cost laparoscopic device.A. Laparoscopic advanced energy device with the laparoscopic surgical smoke extractor attached.B. Water trap.Source: Pictures taken by the authors.Fig. 2

A total of 183 procedures were performed, 97 emergency and 86 elective surgery, in all procedures the use of the described devices were achieved. Of the total number of emergency patients, 9 were COVID-positive, and the rest were tracheostomized; the rest were considered suspicious cases (n = 88), of all these patients, none had postoperative complications associated with COVID-19. Of the 86 patients undergoing elective surgery, none had complications associated with COVID-19. **(** [Table 1](#tbl1){ref-type="table"} **).** Table 1Total of emergency and elective laparoscopic and open procedures.Table 1**OpenMinimally invasive (Laparoscopy/Thoracoscopy)AbdominopelvicThoracicHead & neckSoft tissueAbdominopelvicEmergencyTypeNo.TypeNo.TypeNo.TypeNo.Common bile duct exploration1Coronary artery bypass grafting (CABG)1Tracheostomy9xxApendilap13Hartmann procedure due to sigmoid volvulus1Inguinal hernioplasty10Cholecystectomy due to cholecystitis25Gastrostomy10Umbilica hernia5ElectiveTypeNo.TypeNo.TypeNo.TypeNo.TypeNo.Transverse abdominal release3Aortic valve replacement1Tiroidectomy due to cancer5Varicosafenectomy2Cholecystectomy due to gallbladder polyp1Hartmann closure1Lipoma resection2Ileostomy closure1Mastectomy10Gastric sleeve1Breast bilateral reconstruction protectomy1Right maxillectomy1Cuadrantectomy1Left hemicolectomy1Anal condiloma resection1Rectum anterior resection due to cancer1Gastric bypass4**

In 1996, DesCbteaux et al. described the possible risks of particles contained in aerosols or cautery smoke. So far, it has only been proven the presence of Hepatitis B virus and human papillomavirus DNA in surgical smoke, with no surgical team member contamination. However, until further studies, precautions are necessary.[@bib4]

SARS-CoV-2 virions have an approximate size of 0.125 μm, which are transmitted through larger respiratory water droplets (\>20 μm) and its RNA is mainly detected in samples from the upper and lower respiratory tract. The average incubation period is 5.2 days, patients can develop mild symptoms to respiratory and multiorgan failure or be asymptomatic. The virus can also be aerosolized and transmitted in small water droplets (\<10 μm). Particle size has implications for suspension time and filtration requirements. Until now, no study has identified SARS-CoV-2 in surgical smoke, and even if it is found, it is not known whether these viral particles are infectious.[@bib5]

Due to the recent COVID-19 pandemic, the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) has published different recommendations in order to reduce possible perioperative viral transmission to patients, and healthcare workers. SAGES recommends using devices to smoke and gas evacuation during open, laparoscopic, and endoscopic procedures. Also, in order to save resources, elective surgeries are being postponed. Such decisions must be taken considering region exposure to the virus, national balance and the local priorities.[@bib6]

Other viral epidemics have taught us that the transmission risk of viral diseases with laparoscopy is practically null. Although SARS-CoV-2/COVID-19 is a new disease. Evidence for similar respiratory viruses, such as influenza and other coronaviruses (Severe Acute Respiratory Syndrome - SARS and Middle East Respiratory Syndrome - MERS-CoV), has not demonstrated transmission of the disease through pneumoperitoneum or surgical smoke.

During gastrointestinal surgery, the use of the scalpel and the opening of the digestive tract can generate aerosols. Laparoscopic techniques significantly minimize surgeons' exposure to blood borne pathogens compared to laparotomy. It involves the interposition of a physical barrier between the surgeon and the possible source of contagion, avoiding direct exposure of the surgeon to aerosols potentially contaminated with the virus. Hermetic laparoscopic ports and evacuation/filtration systems can be used to minimize the non-controlled release of aerosols with potential viruses into the operating room environment and allow surgical smoke-controlled extraction (actively or passively). Although smoke evacuation and filtration systems can be used in both open and laparoscopic surgery, laparoscopy offers the unique advantage of containing induced pneumoperitoneum and surgical smoke in the abdominal cavity. Also, safe surgical smoke evacuation during open surgery is difficult, containment of it is challenging or nearly impossible. The surgical smoke evacuator in open surgery should ideally be a maximum of 2 cm from the source. The leak of surgical smoke rises to 50% for every 1 cm of distance from the surgical field.[@bib7]

In order to protect patients and healthcare workers, the Preoperative Assessment, Consultation, & Treatment Clinic (PACT) developed a pre-surgical COVID-19 testing strategy, initially limiting the testing to high-risk aerosolization patients. This was useful by providing safety and confidence to medical staff.[@bib8]

Different surgical groups in the world have proposed systems to perform a safe evacuation of the induced pneumoperitoneum through closed suction or negative pressure systems, with water traps and high-efficiency filters. Allowing greater particles and aerosol control degree during the surgical procedure. Different products available on the market could also be used to remove and filter intraoperative gases such as CO2 and surgical smoke, during open, laparoscopic, and endoscopic procedures, but they have a high cost and that could be a limitation in low and middle-income countries.[@bib9] There is no evidence on the actual literature of low cost alternatives, directed to development countries.

The election of the ideal surgical approach during the SARS-CoV-2/COVID-19 pandemic must consider factors like patient's condition, aerosol generation risk, postoperative hospital stay, and hospital beds available for safe and cost-efficient use of healthcare system resources. However, beyond these reported individual experiences of "low-cost," handmade surgical smoke and induced pneumoperitoneum evacuation systems, there are no comparative studies evaluating their clinical impact, in terms of effectiveness and safely extraction of intraoperative gases.
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